SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphoma
Yue Zhang(Guilin Medical University), Qingjiang Chen(First Affiliated Hospital of Zhengzhou University), Wencai Li(First Affiliated Hospital of Zhengzhou University), Siyu Qian(First Affiliated Hospital of Zhengzhou University), Xiaoshuang Kong(First Affiliated Hospital of Zhengzhou University), Yaxin Lei(First Affiliated Hospital of Zhengzhou University), Canwei Tang(First Affiliated Hospital of Xinxiang Medical University), Mingzhi Zhang(Chinese Academy of Sciences), Guannan Wang(Northeast Normal University), Zeyuan Wang(Central South University), Wenhua Wang(Lanzhou University), Shaoxuan Wu(First Affiliated Hospital of Zhengzhou University), Huting Hou(First Affiliated Hospital of Zhengzhou University), Jingjing Ge(First Affiliated Hospital of Zhengzhou University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Qing Wen(First Affiliated Hospital of Zhengzhou University)
Cited by 6
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134